{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:50:38Z","timestamp":1789851038972,"version":"4.0.1"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI127581"],"award-info":[{"award-number":["R21 AI127581"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI109023"],"award-info":[{"award-number":["R01 AI109023"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01 AI124678"],"award-info":[{"award-number":["R01 AI124678"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI137900"],"award-info":[{"award-number":["R21 AI137900"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI106711"],"award-info":[{"award-number":["T32 AI106711"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UP_1201\/5"],"award-info":[{"award-number":["MC_UP_1201\/5"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 GM008666"],"award-info":[{"award-number":["T32 GM008666"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007722","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:47:11Z","timestamp":1559843231000},"page":"e1007722","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents"],"prefix":"10.1371","volume":"15","author":[{"given":"Barbara H.","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euna","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-8461","authenticated-orcid":true,"given":"James M.","family":"Murithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-1200","authenticated-orcid":true,"given":"Madeline R.","family":"Luth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6353-6895","authenticated-orcid":true,"given":"Pavel","family":"Afanasyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-5747","authenticated-orcid":true,"given":"Paula C. A.","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-2113","authenticated-orcid":true,"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-8453","authenticated-orcid":true,"given":"Caroline L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-4412","authenticated-orcid":true,"given":"Matthew","family":"Bogyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":true,"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. WHO status report on artemisinin resistance and ACT efficacy. 2018. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin-resistance-august2018\/en\" xlink:type=\"simple\">https:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin-resistance-august2018\/en<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","article-title":"Qinghaosu (artemisinin): the price of success","volume":"320","author":"NJ White","year":"2008","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Y Tu","year":"2011","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in P<italic>lasmodium falciparum<\/italic> malaria","volume":"371","author":"EA Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant <italic>Plasmodium falciparum<\/italic> in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"M Imwong","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of artemisinin-resistant <italic>Plasmodium falciparum<\/italic> malaria in Eastern India","volume":"379","author":"S Das","year":"2018","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant <italic>Plasmodium falciparum<\/italic> malaria","volume":"505","author":"F Ariey","year":"2014","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome editing in the human malaria parasite <italic>Plasmodium falciparum<\/italic> using the CRISPR-Cas9 system","volume":"32","author":"M Ghorbal","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in <italic>Plasmodium falciparum<\/italic> clinical isolates","volume":"347","author":"J Straimer","year":"2015","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm1547","article-title":"Function and regulation of cullin-RING ubiquitin ligases","volume":"6","author":"MD Petroski","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/emboj.2013.173","article-title":"The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications","volume":"32","author":"P Genschik","year":"2013","journal-title":"EMBO J"},{"key":"ref12","article-title":"<italic>Plasmodium falciparum<\/italic> Community Project. Genomic epidemiology of artemisinin resistant malaria","volume":"5","author":"GEN Malaria","year":"2016","journal-title":"Elife"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of <italic>Plasmodium falciparum<\/italic> K13-propeller polymorphisms","volume":"374","author":"D Menard","year":"2016","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"S Mok","year":"2015","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of <italic>Plasmodium falciparum<\/italic> to overcome artemisinin resistance","volume":"13","author":"C Dogovski","year":"2015","journal-title":"PLoS Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"JL Bridgford","year":"2018","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"D Voges","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.LAB.0000022226.23741.37","article-title":"Role and function of the 26S proteasome in proliferation and apoptosis","volume":"82","author":"C Naujokat","year":"2002","journal-title":"Lab Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.42.10.2731","article-title":"Proteasome inhibitors block development of <italic>Plasmodium spp<\/italic>","volume":"42","author":"SM Gantt","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/AAC.00088-09","article-title":"The proteasome inhibitor epoxomicin has potent <italic>Plasmodium falciparum<\/italic> gametocytocidal activity","volume":"53","author":"B Czesny","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature16936","article-title":"Structure- and function-based design of <italic>Plasmodium<\/italic>-selective proteasome inhibitors","volume":"530","author":"H Li","year":"2016","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1021\/acs.jmedchem.7b00671","article-title":"Development of a potent inhibitor of the <italic>Plasmodium<\/italic> proteasome with reduced mammalian toxicity","volume":"60","author":"GM LaMonte","year":"2017","journal-title":"J Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"E6863","DOI":"10.1073\/pnas.1806109115","article-title":"Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance","volume":"115","author":"LA Kirkman","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1021\/jacs.8b06656","article-title":"Defining the determinants of specificity of <italic>Plasmodium<\/italic> proteasome inhibitors","volume":"140","author":"E Yoo","year":"2018","journal-title":"J Am Chem Soc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1021\/acs.jmedchem.8b01161","article-title":"Target validation and identification of novel boronate inhibitors of the <italic>Plasmodium falciparum<\/italic> proteasome","volume":"61","author":"SC Xie","year":"2018","journal-title":"J Med Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/cb5001263","article-title":"Assessing subunit dependency of the <italic>Plasmodium<\/italic> proteasome using small molecule inhibitors and active site probes","volume":"9","author":"H Li","year":"2014","journal-title":"ACS Chem Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.1104063108","article-title":"Artemisinin activity against <italic>Plasmodium falciparum<\/italic> requires hemoglobin uptake and digestion","volume":"108","author":"N Klonis","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1073\/pnas.1217452110","article-title":"Altered temporal response of malaria parasites determines differential sensitivity to artemisinin","volume":"110","author":"N Klonis","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1242\/jcs.178830","article-title":"Haemoglobin degradation underpins the sensitivity of early ring stage <italic>Plasmodium falciparum<\/italic> to artemisinins","volume":"129","author":"SC Xie","year":"2016","journal-title":"J Cell Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant <italic>Plasmodium falciparum<\/italic> malaria in Cambodia: <italic>in-vitro<\/italic> and <italic>ex-vivo<\/italic> drug-response studies","volume":"13","author":"B Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/AAC.00857-16","article-title":"Endoperoxide drug cross-resistance patterns for <italic>Plasmodium falciparum<\/italic> exhibiting an artemisinin delayed-clearance phenotype","volume":"60","author":"A Siriwardana","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e00172","DOI":"10.1128\/mBio.00172-17","article-title":"<italic>Plasmodium falciparum<\/italic> K13 mutations differentially impact ozonide susceptibility and parasite fitness <italic>in vitro<\/italic>","volume":"8","author":"J Straimer","year":"2017","journal-title":"MBio"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e0154166","DOI":"10.1371\/journal.pone.0154166","article-title":"Evidence of a mild mutator phenotype in Cambodian <italic>Plasmodium falciparum<\/italic> malaria parasites.","volume":"11","author":"AH Lee","year":"2016","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using <italic>in vitro<\/italic> evolution and chemogenomics","volume":"359","author":"AN Cowell","year":"2018","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1000243","DOI":"10.1371\/journal.pgen.1000243","article-title":"Adaptive copy number evolution in malaria parasites","volume":"4","author":"S Nair","year":"2008","journal-title":"PLoS Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/molbev\/msu140","article-title":"Origin of robustness in generating drug-resistant malaria parasites","volume":"31","author":"K Kumpornsin","year":"2014","journal-title":"Mol Biol Evol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1073\/pnas.90.17.8292","article-title":"Genes necessary for expression of a virulence determinant and for transmission of <italic>Plasmodium falciparum<\/italic> are located on a 0.3-megabase region of chromosome 9","volume":"90","author":"KP Day","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.chembiol.2006.09.013","article-title":"A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes <italic>in vitro<\/italic> and <italic>in vivo<\/italic>","volume":"13","author":"M Verdoes","year":"2006","journal-title":"Chem Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/febs.14016","article-title":"Activity-based probes for the multicatalytic proteasome","volume":"284","author":"DS Hewings","year":"2017","journal-title":"FEBS J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1111\/febs.13780","article-title":"The cryo-EM structure of the <italic>Plasmodium falciparum<\/italic> 20S proteasome and its use in the fight against malaria","volume":"283","author":"H Li","year":"2016","journal-title":"FEBS J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/acsinfecdis.5b00090","article-title":"Monoclonal antibodies that recognize the alkylation signature of antimalarial ozonides OZ277 (Arterolane) and OZ439 (Artefenomel).","volume":"2","author":"J Jourdan","year":"2016","journal-title":"ACS Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1002\/anie.201512062","article-title":"A click chemistry-based proteomic approach reveals that 1,2,4-Trioxolane and artemisinin antimalarials share a common protein alkylation profile","volume":"55","author":"HM Ismail","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in <italic>Plasmodium<\/italic>","volume":"16","author":"K Haldar","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/expr.1995.1049","article-title":"Interactions of atovaquone with other antimalarial drugs against <italic>Plasmodium falciparum in vitro<\/italic>","volume":"80","author":"CJ Canfield","year":"1995","journal-title":"Exp Parasitol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1128\/AAC.00882-09","article-title":"Role of <italic>Plasmodium falciparum<\/italic> digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors","volume":"53","author":"PA Moura","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/AAC.01566-10","article-title":"<italic>In vivo<\/italic> and <italic>in vitro<\/italic> antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine","volume":"55","author":"MR Pereira","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"14574","DOI":"10.1038\/ncomms14574","article-title":"A potent antimalarial benzoxaborole targets a <italic>Plasmodium falciparum<\/italic> cleavage and polyadenylation specificity factor homologue","volume":"8","author":"E Sonoiki","year":"2017","journal-title":"Nat Commun"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/mmi.13397","article-title":"CRISPR-Cas9-modified <italic>pfmdr1<\/italic> protects <italic>Plasmodium falciparum<\/italic> asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs","volume":"101","author":"CL Ng","year":"2016","journal-title":"Mol Microbiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4269\/ajtmh.1983.32.221","article-title":"Effects of antibiotics on <italic>Plasmodium falciparum in vitro<\/italic>","volume":"32","author":"TG Geary","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"B Baragana","year":"2015","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent <italic>Plasmodium falciparum<\/italic> dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"JM Coteron","year":"2011","journal-title":"J Med Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"288ra77","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"JD Herman","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"M Rottmann","year":"2010","journal-title":"Science"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking <italic>Plasmodium falciparum<\/italic> parasite biology to the clinic","volume":"23","author":"B Blasco","year":"2017","journal-title":"Nat Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria.","volume":"3","author":"MA Phillips","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1473-3099(18)30309-8","article-title":"Antimalarial activity of single-dose DSM265, a novel <italic>Plasmodium<\/italic> dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated <italic>Plasmodium falciparum<\/italic> or <italic>Plasmodium vivax<\/italic> malaria infection: a proof-of-concept, open-label, phase 2a study","volume":"18","author":"A Llanos-Cuentas","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.15698\/mic2016.05.503","article-title":"Chemical proteomics approach reveals the direct targets and the heme-dependent activation mechanism of artemisinin in <italic>Plasmodium falciparum<\/italic> using an artemisinin-based activity probe","volume":"3","author":"J Wang","year":"2016","journal-title":"Microb Cell"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1073\/pnas.1600459113","article-title":"Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites <italic>Plasmodium falciparum<\/italic> 3D7","volume":"113","author":"HM Ismail","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","article-title":"Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with <italic>Plasmodium falciparum<\/italic> and <italic>Plasmodium vivax<\/italic> malaria: an open-label phase 2 trial","volume":"16","author":"AP Phyo","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12916-017-0940-3","article-title":"A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated <italic>Plasmodium falciparum<\/italic> malaria","volume":"15","author":"F Macintyre","year":"2017","journal-title":"BMC Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of <italic>Plasmodium falciparum<\/italic> sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"SH Adjalley","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/infdis\/jiu540","article-title":"Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for <italic>falciparum<\/italic> malaria in children: a randomized controlled trial in Burkina Faso","volume":"211","author":"B Coulibaly","year":"2015","journal-title":"J Infect Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/mmi.13626","article-title":"A high susceptibility to redox imbalance of the transmissible stages of <italic>Plasmodium falciparum<\/italic> revealed with a luciferase-based mature gametocyte assay","volume":"104","author":"G Siciliano","year":"2017","journal-title":"Mol Microbiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj20020962","article-title":"Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant <italic>Plasmodium falciparum<\/italic>","volume":"368","author":"S Meierjohann","year":"2002","journal-title":"Biochem J"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.3390\/molecules200610511","article-title":"Role and regulation of glutathione metabolism in <italic>Plasmodium falciparum<\/italic>","volume":"20","author":"S Muller","year":"2015","journal-title":"Molecules"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1128\/AAC.49.11.4592-4597.2005","article-title":"<italic>In vitro<\/italic> assessment of methylene blue on chloroquine-sensitive and -resistant <italic>Plasmodium falciparum<\/italic> strains reveals synergistic action with artemisinins","volume":"49","author":"M Akoachere","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02214-17","article-title":"Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in <italic>Plasmodium falciparum<\/italic> transmissible gametocyte stages","volume":"62","author":"D Coertzen","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/cbdd.12571","article-title":"Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15","volume":"86","author":"X Wang","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"17818","DOI":"10.1038\/srep17818","article-title":"Characterization of the 26S proteasome network in <italic>Plasmodium falciparum<\/italic>","volume":"5","author":"L Wang","year":"2015","journal-title":"Sci Rep"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of proteasome deubiquitinating activity as a new cancer therapy","volume":"17","author":"P D'Arcy","year":"2011","journal-title":"Nat Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1091\/mbc.e03-07-0506","article-title":"Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin","volume":"15","author":"E Fiebiger","year":"2004","journal-title":"Mol Biol Cell"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1083\/jcb.201312042","article-title":"Quality control: ER-associated degradation: protein quality control and beyond","volume":"204","author":"A Ruggiano","year":"2014","journal-title":"J Cell Biol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e15479","DOI":"10.1371\/journal.pone.0015479","article-title":"The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97\/VCP inhibitory group","volume":"5","author":"Q Wang","year":"2010","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2012.10.021","article-title":"Eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression","volume":"128","author":"GJ Brem","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"U Schubert","year":"2000","journal-title":"Nature"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"e00303","DOI":"10.1128\/mBio.00303-17","article-title":"A variant PfCRT isoform can contribute to <italic>Plasmodium falciparum<\/italic> resistance to the first-line partner drug piperaquine","volume":"8","author":"SK Dhingra","year":"2017","journal-title":"MBio"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"12870","DOI":"10.1074\/jbc.M708949200","article-title":"<italic>Plasmodium<\/italic> food vacuole plasmepsins are activated by falcipains","volume":"283","author":"ME Drew","year":"2008","journal-title":"J Biol Chem"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.11-187401","article-title":"Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches","volume":"25","author":"EH Ekland","year":"2011","journal-title":"FASEB J"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2105-15-63","article-title":"Identification of pathogen genomic variants through an integrated pipeline","volume":"15","author":"MJ Manary","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"11.01","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"GA Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of <italic>Drosophila melanogaster<\/italic> strain w1118; iso-2; iso-3","volume":"6","author":"P Cingolani","year":"2012","journal-title":"Fly"},{"key":"ref82","article-title":"Amber 2014","author":"D Case","year":"2014"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:30:10Z","timestamp":1694935810000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007722"}},"subtitle":[],"editor":[{"given":"Michael J.","family":"Blackman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":82,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007722","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]}}}